Arcutis Biotherapeutics

ARQTNasdaq United States Health Care Biotechnology: Pharmaceutical Preparations

Market cap

$3.179 B

$25.29 -4.31%

Close of 7 Aug 2026

Revenue

$376.1M

#2053 by revenue

Earnings

-$16.1M

Loss-making

Shares outstanding

125,691,961

Latest filing cover page

P/E ratio

—

Cap ÷ net income

Biotechnology: Pharmaceutical Preparations — ranked by market cap

All 501 →

#79MBX BiosciencesMBX$3.23B
#80uniQureQURE$3.22B
#81Arcutis BiotherapeuticsARQT$3.18B
#82Disc MedicineIRON$2.97B
#83ImmunomeIMNM$2.83B

Where these numbers come from

Share counts and financials for Arcutis Biotherapeutics are taken from its own SEC filings via EDGAR — public record, not an estimate. Market cap is shares outstanding multiplied by the latest close. Last updated 9 Aug 2026. Read the methodology.